• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Survival of hepatitis C virus in syringes: implication for transmission among injection drug users.注射器中丙型肝炎病毒的存活:对注射吸毒者之间传播的影响。
J Infect Dis. 2010 Oct 1;202(7):984-90. doi: 10.1086/656212.
2
Recovery of Infectious Hepatitis C Virus From Injection Paraphernalia: Implications for Prevention Programs Serving People Who Inject Drugs.从注射用具中回收丙型肝炎病毒:对为注射吸毒者服务的预防规划的影响。
J Infect Dis. 2018 Jan 17;217(3):466-473. doi: 10.1093/infdis/jix427.
3
Survival of Hepatitis C Virus in Syringes Is Dependent on the Design of the Syringe-Needle and Dead Space Volume.丙型肝炎病毒在注射器中的存活情况取决于注射器-针头的设计和死腔容积。
PLoS One. 2015 Nov 4;10(11):e0139737. doi: 10.1371/journal.pone.0139737. eCollection 2015.
4
Surveillance of HIV, hepatitis B virus, and hepatitis C virus in an estonian injection drug-using population: sensitivity and specificity of testing syringes for public health surveillance.爱沙尼亚注射吸毒人群中艾滋病毒、乙型肝炎病毒和丙型肝炎病毒的监测:用于公共卫生监测的注射器检测的敏感性和特异性
J Infect Dis. 2006 Feb 1;193(3):455-7. doi: 10.1086/499436. Epub 2005 Dec 22.
5
Presence of hepatitis C virus in syringes confiscated in prisons in Australia.在澳大利亚监狱没收的注射器中存在丙型肝炎病毒。
J Gastroenterol Hepatol. 2009 Oct;24(10):1655-7. doi: 10.1111/j.1440-1746.2009.05978.x.
6
Hepatitis C transmission in injection drug users: could swabs be the main culprit?注射吸毒者中的丙型肝炎传播:拭子可能是主要罪魁祸首?
J Infect Dis. 2011 Dec 15;204(12):1839-42. doi: 10.1093/infdis/jir650. Epub 2011 Oct 19.
7
Hepatitis C virus maintains infectivity for weeks after drying on inanimate surfaces at room temperature: implications for risks of transmission.丙型肝炎病毒在室温下的无生命表面干燥后仍能保持数周的传染性:对传播风险的影响。
J Infect Dis. 2014 Apr 15;209(8):1205-11. doi: 10.1093/infdis/jit648. Epub 2013 Nov 23.
8
Disinfection of syringes contaminated with hepatitis C virus by rinsing with household products.家用产品冲洗污染丙型肝炎病毒的注射器的消毒作用。
Open Forum Infect Dis. 2015 Feb 23;2(1):ofv017. doi: 10.1093/ofid/ofv017. eCollection 2015 Jan.
9
Does bleach disinfection of syringes protect against hepatitis C infection among young adult injection drug users?对注射器进行漂白剂消毒能否预防年轻成年注射吸毒者感染丙型肝炎?
Epidemiology. 2002 Nov;13(6):738-41. doi: 10.1097/00001648-200211000-00023.
10
Modeling of patient virus titers suggests that availability of a vaccine could reduce hepatitis C virus transmission among injecting drug users.患者病毒滴度模型表明,疫苗的可及性可以降低注射吸毒者中丙型肝炎病毒的传播。
Sci Transl Med. 2018 Jul 11;10(449). doi: 10.1126/scitranslmed.aao4496.

引用本文的文献

1
Drug use and sexual behaviors among women who inject drugs and use a syringe services program; Miami, Florida.注射毒品并使用注射器服务项目的女性中的药物使用及性行为;佛罗里达州迈阿密
Harm Reduct J. 2025 Jul 7;22(1):117. doi: 10.1186/s12954-025-01266-0.
2
Elimination of HCV Infection: Recent Epidemiological Findings, Barriers, and Strategies for the Coming Years.消除 HCV 感染:近年流行病学发现、障碍及未来策略。
Viruses. 2024 Nov 19;16(11):1792. doi: 10.3390/v16111792.
3
Prevalence and associated risk factors of hepatitis C antibody and RNA among people who inject drugs in Puerto Rico.波多黎各注射吸毒人群中丙型肝炎抗体和 RNA 的流行情况及相关危险因素。
J Subst Use Addict Treat. 2024 May;160:209308. doi: 10.1016/j.josat.2024.209308. Epub 2024 Jan 30.
4
Elucidating the role of environmental management of forests, air quality, solid waste and wastewater on the dissemination of SARS-CoV-2.阐明森林环境管理、空气质量、固体废物和废水管理对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)传播的作用。
Hyg Environ Health Adv. 2022 Sep;3:100006. doi: 10.1016/j.heha.2022.100006. Epub 2022 May 10.
5
6th Canadian Symposium on Hepatitis C Virus: Delivering a cure for hepatitis C infection-What are the remaining gaps?第六届加拿大丙型肝炎病毒研讨会:实现丙型肝炎感染的治愈——尚存哪些差距?
Can Liver J. 2018 Jul 17;1(2):94-105. doi: 10.3138/canlivj.1.2.008. eCollection 2018 Spring.
6
Viral hepatitis: Past, present, and future.病毒性肝炎:过去、现在和未来。
World J Gastroenterol. 2022 Apr 14;28(14):1405-1429. doi: 10.3748/wjg.v28.i14.1405.
7
The Effectiveness of Low Dead Space Syringes for Reducing the Risk of Hepatitis C Virus Acquisition Among People Who Inject Drugs: Findings From a National Survey in England, Wales, and Northern Ireland.低死腔注射器在降低注射吸毒人群丙型肝炎病毒感染风险中的效果:来自英格兰、威尔士和北爱尔兰全国性调查的结果。
Clin Infect Dis. 2022 Sep 29;75(6):1073-1077. doi: 10.1093/cid/ciac140.
8
Non-Vertical Exposures to HIV, HBV and HCV Infection in Children and Adolescents-Risk of Infection, Standards of Care and Postexposure Prophylaxis.儿童和青少年非垂直暴露于艾滋病毒、乙肝病毒和丙肝病毒感染——感染风险、护理标准和暴露后预防
Pediatr Rep. 2021 Oct 13;13(4):566-575. doi: 10.3390/pediatric13040067.
9
Evaluating the Virucidal Activity of Disinfectants According to European Union Standards.评估消毒剂根据欧盟标准的病毒杀灭活性。
Viruses. 2021 Mar 24;13(4):534. doi: 10.3390/v13040534.
10
Opportunities to Offer Harm Reduction to People who Inject Drugs During Infectious Disease Encounters: Narrative Review.在传染病诊疗过程中为注射吸毒者提供减少伤害服务的机会:叙述性综述
Open Forum Infect Dis. 2020 Oct 20;7(11):ofaa503. doi: 10.1093/ofid/ofaa503. eCollection 2020 Nov.

本文引用的文献

1
Hepatitis C virus infection among drug injectors in St Petersburg, Russia: social and molecular epidemiology of an endemic infection.俄罗斯圣彼得堡吸毒者中的丙型肝炎病毒感染:地方性感染的社会和分子流行病学。
Addiction. 2009 Nov;104(11):1881-90. doi: 10.1111/j.1360-0443.2009.02687.x. Epub 2009 Aug 27.
2
Hepatitis C virus NS2 protein contributes to virus particle assembly via opposing epistatic interactions with the E1-E2 glycoprotein and NS3-NS4A enzyme complexes.丙型肝炎病毒NS2蛋白通过与E1-E2糖蛋白和NS3-NS4A酶复合物的上位性相互作用来促进病毒粒子组装。
J Virol. 2009 Sep;83(17):8379-95. doi: 10.1128/JVI.00891-09. Epub 2009 Jun 10.
3
High dead-space syringes and the risk of HIV and HCV infection among injecting drug users.大容量注射器与注射吸毒者感染艾滋病毒和丙肝病毒的风险。
Drug Alcohol Depend. 2009 Mar 1;100(3):204-13. doi: 10.1016/j.drugalcdep.2008.08.017. Epub 2008 Nov 11.
4
Protein kinase A-dependent step(s) in hepatitis C virus entry and infectivity.丙型肝炎病毒进入和感染过程中依赖蛋白激酶A的步骤。
J Virol. 2008 Sep;82(17):8797-811. doi: 10.1128/JVI.00592-08. Epub 2008 Jun 25.
5
Understanding the impact of male circumcision interventions on the spread of HIV in southern Africa.了解男性包皮环切术干预措施对南部非洲艾滋病毒传播的影响。
PLoS One. 2008 May 21;3(5):e2212. doi: 10.1371/journal.pone.0002212.
6
The spread, treatment, and prevention of HIV-1: evolution of a global pandemic.人类免疫缺陷病毒1型(HIV-1)的传播、治疗与预防:一场全球大流行的演变
J Clin Invest. 2008 Apr;118(4):1244-54. doi: 10.1172/JCI34706.
7
Seroprevalence of hepatitis C virus and hepatitis B virus among San Francisco injection drug users, 1998 to 2000.1998年至2000年旧金山注射吸毒者中丙型肝炎病毒和乙型肝炎病毒的血清流行率。
Hepatology. 2007 Sep;46(3):666-71. doi: 10.1002/hep.21765.
8
Community characteristics associated with HIV risk among injection drug users in the San Francisco Bay Area: a multilevel analysis.旧金山湾区注射吸毒者中与艾滋病毒风险相关的社区特征:一项多层次分析。
J Urban Health. 2007 Sep;84(5):653-66. doi: 10.1007/s11524-007-9213-3. Epub 2007 Jul 27.
9
Hepatitis C virus p7 and NS2 proteins are essential for production of infectious virus.丙型肝炎病毒p7和NS2蛋白对于传染性病毒的产生至关重要。
J Virol. 2007 Aug;81(16):8374-83. doi: 10.1128/JVI.00690-07. Epub 2007 May 30.
10
Infectivity of hepatitis C virus in plasma after drying and storing at room temperature.丙型肝炎病毒在室温下干燥和储存后血浆中的传染性。
Infect Control Hosp Epidemiol. 2007 May;28(5):519-24. doi: 10.1086/513727. Epub 2007 Apr 16.

注射器中丙型肝炎病毒的存活:对注射吸毒者之间传播的影响。

Survival of hepatitis C virus in syringes: implication for transmission among injection drug users.

机构信息

Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut 06520, USA.

出版信息

J Infect Dis. 2010 Oct 1;202(7):984-90. doi: 10.1086/656212.

DOI:10.1086/656212
PMID:20726768
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2932767/
Abstract

BACKGROUND

We hypothesized that the high prevalence of hepatitis C virus (HCV) among injection drug users might be due to prolonged virus survival in contaminated syringes.

METHODS

We developed a microculture assay to examine the viability of HCV. Syringes were loaded with blood spiked with HCV reporter virus (Jc1/GLuc2A) to simulate 2 scenarios of residual volumes: low void volume (2 microL) for 1-mL insulin syringes and high void volume (32 microL) for 1-mL tuberculin syringes. Syringes were stored at 4 degrees C, 22 degrees C, and 37 degrees C for up to 63 days before testing for HCV infectivity by using luciferase activity.

RESULTS

The virus decay rate was biphasic (t1/2alpha= 0.4 h and t1/2beta = 28 hh). Insulin syringes failed to yield viable HCV beyond day 1 at all storage temperatures except 4 degrees , in which 5% of syringes yielded viable virus on day 7. Tuberculin syringes yielded viable virus from 96%, 71%, and 52% of syringes after storage at 4 degrees, 22 degrees, and 37 degrees for 7 days, respectively, and yielded viable virus up to day 63.

CONCLUSIONS

The high prevalence of HCV among injection drug users may be partly due to the resilience of the virus and the syringe type. Our findings may be used to guide prevention strategies.

摘要

背景

我们假设在注射吸毒者中丙型肝炎病毒(HCV)的高流行率可能是由于污染的注射器中病毒存活时间延长所致。

方法

我们开发了一种微培养测定法来检查 HCV 的活力。将血液与 HCV 报告病毒(Jc1/GLuc2A)混合装入注射器中,模拟两种剩余体积情况:1 毫升胰岛素注射器的低空隙体积(2 微升)和 1 毫升结核菌素注射器的高空隙体积(32 微升)。将注射器在 4°C、22°C 和 37°C 下储存长达 63 天,然后通过荧光素酶活性检测 HCV 的感染性。

结果

病毒衰减呈两相(t1/2alpha=0.4 h 和 t1/2beta=28 hh)。除 4°C 外,所有储存温度下胰岛素注射器在第 1 天之后都未能产生有活力的 HCV,而在 4°C 下,第 7 天有 5%的注射器产生有活力的病毒。结核菌素注射器在 4°C、22°C 和 37°C 下储存 7 天后,分别有 96%、71%和 52%的注射器产生有活力的病毒,并且直到第 63 天仍能产生有活力的病毒。

结论

注射吸毒者中 HCV 的高流行率可能部分归因于病毒和注射器类型的弹性。我们的发现可用于指导预防策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2791/2932767/c445f7f8a87f/nihms219637f4a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2791/2932767/d563fc32c376/nihms219637f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2791/2932767/ccfe2434d923/nihms219637f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2791/2932767/6fcf31cb1a44/nihms219637f3a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2791/2932767/c445f7f8a87f/nihms219637f4a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2791/2932767/d563fc32c376/nihms219637f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2791/2932767/ccfe2434d923/nihms219637f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2791/2932767/6fcf31cb1a44/nihms219637f3a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2791/2932767/c445f7f8a87f/nihms219637f4a.jpg